Mehmet Altintas to Kidney Diseases
This is a "connection" page, showing publications Mehmet Altintas has written about Kidney Diseases.
Connection Strength
2.090
-
Renal cell markers: lighthouses for managing renal diseases. Am J Physiol Renal Physiol. 2021 12 01; 321(6):F715-F739.
Score: 0.746
-
More expression, less function: cleaved dynamin in glomerular kidney disease. J Pathol. 2019 Apr; 247(4):413-415.
Score: 0.618
-
The D2D3 form of uPAR acts as an immunotoxin and may cause diabetes and kidney disease. Sci Transl Med. 2023 09 20; 15(714):eabq6492.
Score: 0.213
-
TRPC5 Does Not Cause or Aggravate Glomerular Disease. J Am Soc Nephrol. 2018 02; 29(2):409-415.
Score: 0.142
-
Prkdc participates in mitochondrial genome maintenance and prevents Adriamycin-induced nephropathy in mice. J Clin Invest. 2010 Nov; 120(11):4055-64.
Score: 0.087
-
Enzymatic disease of the podocyte. Pediatr Nephrol. 2010 Jun; 25(6):1017-23.
Score: 0.083
-
Proteolytic processing of dynamin by cytoplasmic cathepsin L is a mechanism for proteinuric kidney disease. J Clin Invest. 2007 Aug; 117(8):2095-104.
Score: 0.070
-
Induction of TRPC6 channel in acquired forms of proteinuric kidney disease. J Am Soc Nephrol. 2007 Jan; 18(1):29-36.
Score: 0.067
-
High-content screening assay-based discovery of paullones as novel podocyte-protective agents. Am J Physiol Renal Physiol. 2018 02 01; 314(2):F280-F292.
Score: 0.035
-
A Podocyte-Based Automated Screening Assay Identifies Protective Small Molecules. J Am Soc Nephrol. 2015 Nov; 26(11):2741-52.
Score: 0.030